Mary L. Smith
CIK: 0001866044
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTC THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
Exercise(M)Direct10K shares at avg. $42.95$430K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
Sale(S)Direct10K shares at avg. $90.00$900K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
Exercise(M)Direct5.8K shares at avg. $42.95$251K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
Sale(S)Direct5.8K shares at avg. $90.00$525K - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares- - Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise(M) | 10,000 | $42.95 | $429,500 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale(S) | 10,000 | $90.00 | $900,000 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise(M) | 5,834 | $42.95 | $250,570 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale(S) | 5,834 | $90.00 | $525,060 | Direct |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
1-6 of 6 transactions
About Smith Mary L.
Smith Mary L. (SEC CIK 0001866044) files insider reports with the SEC as Director of PTC THERAPEUTICS, INC. (PTCT).
Signal8 holds 3 ownership filings by Smith Mary L., all Form 4s, filed between Jan 7, 2025 and Jul 13, 2026. Those filings report 6 transactions, from Jan 3, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Smith Mary L.'s filings is in WARREN, NJ.
Recent filings by Smith Mary L.
- Jul 9, 2026: Option exercise of PTCT shares (Form 4, code M).
- Jul 9, 2026: Open-market sale of PTCT shares (Form 4, code S).
- Jul 9, 2026: Option exercise of PTCT shares (Form 4, code M).
- Jul 9, 2026: Open-market sale of PTCT shares (Form 4, code S).
- Jan 2, 2026: Grant or award of PTCT shares (Form 4, code A).
Other insiders filing for PTC THERAPEUTICS, INC. (PTCT)
- SCHMERTZLER MICHAEL, Director
- Boulding Mark Elliott, EXEC. VP AND CLO
- STEELE GLENN JR MD PHD, Director
- Klein Matthew B., CHIEF EXECUTIVE OFFICER
- Sollie-Zetlmayer Hege Elisabeth, Director
- Gravier Pierre, CHIEF FINANCIAL OFFICER